Q2 2024 Holdings
Filed 2024-08-14 | 60 holdings | $3.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aslan Pharmaceuticals LTD | SPON ADS NEW | 04522R200 | $315.0K | 1,049,999 | 0.0% |
| Molecular Templates Inc | COM NEW | 608550208 | $600.6K | 522,238 | 0.0% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $820.5K | 190,815 | 0.0% |
| Unicycive Therapeutics Inc | COM | 90466Y103 | $1.1M | 2,200,000 | 0.0% |
| NLS Pharmaceutics LTD | SHS | H57830103 | $1.2M | 5,747,126 | 0.0% |
| Engene Holdings Inc(ENGNW) | *W EXP 10/31/202 | 29286M113 | $1.3M | 945,402 | 0.0% |
| Forte Biosciences Inc(TOCAEUR) | COM | 34962G109 | $1.6M | 2,982,105 | 0.0% |
| Viracta Therapeutics Inc | COM | 92765F108 | $2.0M | 3,614,662 | 0.1% |
| Inventiva SA(IVA) | ADS | 46124U107 | $2.0M | 686,040 | 0.1% |
| Pieris Pharmaceuticals Inc | COM NEW | 720795202 | $2.5M | 257,626 | 0.1% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $2.7M | 9,544,262 | 0.1% |
| SAB Biotherapeutics Inc(SABS) | COM NEW | 78397T202 | $2.8M | 917,826 | 0.1% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $3.0M | 3,853,818 | 0.1% |
| Molecular Partners AG(MOLN) | ADS | 60853G106 | $3.2M | 443,221 | 0.1% |
| Verve Therapeutics Inc | COM | 92539P101 | $3.2M | 650,000 | 0.1% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $4.1M | 343,055 | 0.1% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $5.0M | 1,685,219 | 0.1% |
| Elevation Oncology Inc | COM | 28623U101 | $6.2M | 2,312,200 | 0.2% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $6.4M | 5,228,461 | 0.2% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $7.0M | 2,000,000 | 0.2% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $7.3M | 1,813,633 | 0.2% |
| Ikena Oncology Inc | COM | 45175G108 | $7.9M | 4,769,164 | 0.2% |
| Immunic Inc(IMUX) | COM | 4525EP101 | $9.9M | 8,902,972 | 0.3% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $16.6M | 16,552,417 | 0.5% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $16.6M | 6,293,282 | 0.5% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $17.5M | 2,989,474 | 0.5% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $18.5M | 441,528 | 0.5% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $21.2M | 2,251,037 | 0.6% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $29.0M | 2,742,409 | 0.8% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $29.2M | 1,521,948 | 0.8% |
| Calliditas Therapeutics AB | SPONSERED ADS | 13124Q106 | $29.2M | 750,000 | 0.8% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $30.5M | 5,302,000 | 0.9% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $34.1M | 10,333,600 | 1.0% |
| Annexon Inc(ANNX) | COM | 03589W102 | $34.3M | 7,000,000 | 1.0% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $38.9M | 1,569,422 | 1.1% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $40.8M | 1,162,306 | 1.1% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $46.0M | 8,748,629 | 1.3% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $50.0M | 5,870,000 | 1.4% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $51.3M | 1,190,107 | 1.4% |
| Third Harmonic BIO Inc(THRD) | COM | 88427A107 | $56.8M | 4,365,933 | 1.6% |
| Celcuity Inc(CELC) | COM | 15102K100 | $56.8M | 3,466,000 | 1.6% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $60.6M | 7,568,479 | 1.7% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $74.5M | 4,661,194 | 2.1% |
| AC Immune SA(ACIU) | SHS | H00263105 | $75.2M | 18,834,936 | 2.1% |
| Merus N V | COM | N5749R100 | $75.7M | 1,279,049 | 2.1% |
| CG Oncology Inc(CGON) | COM | 156944100 | $76.3M | 2,417,885 | 2.1% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $76.9M | 955,000 | 2.2% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $82.3M | 3,922,413 | 2.3% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $84.0M | 4,082,037 | 2.4% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $86.1M | 3,633,743 | 2.4% |